Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase II Randomized Trial of Radiotherapy With Concurrent and Adjuvant Pembrolizumab (Keytruda®) Versus Concurrent Chemotherapy in Patients With Advanced/Intermediate-Risk p16+ Head and Neck Squamous Cell Carcinoma (KEYCHAIN)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03383094
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:12.629817+00:00
Published At
2025-10-07T00:00:00+00:00
Record Updated At
2025-10-07
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Head and Neck Squamous Cell Carcinoma", "Cancer", "Cancer of Head and Neck", "Cancer, Advanced", "Cancer, Metastatic", "Tumor", "Tumor Recurrence", "Tumor Neck", "Tumor Metastasis", "Oral Cancer", "Oropharyngeal Cancer", "Oropharynx Cancer", "Oropharynx Cancer, Stage III", "Oropharynx Cancer, Recurrent", "Oropharynx Cancer, Metastatic"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-10-07"
protocolSection.identificationModule.nctId
"NCT03383094"
protocolSection.identificationModule.officialTitle
"Phase II Randomized Trial of Radiotherapy With Concurrent and Adjuvant Pembrolizumab (Keytruda\u00ae) Versus Concurrent Chemotherapy in Patients With Advanced/Intermediate-Risk p16+ Head and Neck Squamous Cell Carcinoma (KEYCHAIN)"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Head and Neck Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Cancer (protocolSection.conditionsModule.conditions)
  • Cancer of Head and Neck (protocolSection.conditionsModule.conditions)
  • Cancer, Advanced (protocolSection.conditionsModule.conditions)
  • Cancer, Metastatic (protocolSection.conditionsModule.conditions)
  • Tumor (protocolSection.conditionsModule.conditions)
  • Tumor Recurrence (protocolSection.conditionsModule.conditions)
  • Tumor Neck (protocolSection.conditionsModule.conditions)
  • Tumor Metastasis (protocolSection.conditionsModule.conditions)
  • Oral Cancer (protocolSection.conditionsModule.conditions)
  • Oropharyngeal Cancer (protocolSection.conditionsModule.conditions)
  • Oropharynx Cancer (protocolSection.conditionsModule.conditions)
  • Oropharynx Cancer, Stage III (protocolSection.conditionsModule.conditions)
  • Oropharynx Cancer, Recurrent (protocolSection.conditionsModule.conditions)
  • Oropharynx Cancer, Metastatic (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.